蒽环类药物所致心脏毒性的研究现状

王 竹1, 顾 涛2, 刘 立杰2, 张 双2, 白 立立2
1、承德医学院
2、秦皇岛市第一医院

摘要


蒽环类药物是最有效和最常用的抗肿瘤药物之一，可有效对抗广谱实体瘤和白血病。不幸的是，心脏毒性副作用严重
限制了它们的使用。当前，蒽环类药物所致的心脏毒性尚未研究出有效的治疗方法，所以早期监测和预防蒽环类药物所致的心
脏毒性的发生十分重要。本文就蒽环类药物心脏毒性的分类、发展机制、心脏监测以及治疗和预防的新概念作一综述。

关键词


蒽环类药物 ；心脏毒性 ；发展机制 ；治疗与预防

全文:

PDF


参考


[1] Fujimori A. Cloning and mapping of Np95 gene

which encodes a novel nuclear protein associated with cell

proliferation [J]. Mamm Genome,1998,9(12):1032-1035.

[2] 马韬 , 朱正纲 .DPD 及其抑制剂 [J]. 国外医学肿

瘤学分册 ,2002,29(l):139-142.

[3] Martins-Teixeira MB, Carvalho I. Antitumour

Anthracyclines: Progress and Perspectives[J].

ChemMedChem,2020,15(11): 933-948.

[4] Early Breast Cancer Trialists’ Collaborative

Group (EBCTCG), Lancet 2012,379,432-444. OLIVEIRA

G H, AL-KINDI S G, CAIMI P F, et al. Maximizing

anthracycline tolerability in hematologic malignancies: Treat

to each heart's content[J]. Blood Reviews, 2016,30(3):169-

178.

[5] Patanè S. Cardiotoxicity: anthracyclines and long

term cancer survivors[J].Int J Cardiol,2014.176(3):1326-8.

[6] 郑梦颖 , 陈晓品 . 化疗药物对重要脏器不良反应

的研究进展 . 重庆医学 ,2012,41(14):1431-1433.

[7] Narezkina A. Molecular mechanisms of

anthracycline cardiovascular toxicity[J].Clin Sci (Lond),2021,

135(10):1311-1332.

[8] Screever EM. Age-related considerations in cardiooncology[J].J Cardiovasc Pharmacol Ther,2021,26(2):103-

113.

[9] Sobczuk P. Anthracycline-induced cardiotoxicity

and renin-angiotensin-aldosterone system-from molecular

mechanisms to therapeutic applications[J].Heart Fail

Rev,2022(27):296–319.

[10] Plana JC. Expert consensus for multimodality

imaging evaluation of adult patients during and

after cancer therapy: a report from the American

Society of Echocardiography and the European

Association of Cardio-vascular Imaging[J].J Am Soc

Echocardiogr,2014(27):911–39.

[11] Lotrionte M. Review and meta-analysis

of incidence and clinical predic-tors of anthracycline

cardiotoxicity[J].Am J Cardiol,2013(112):1980.

[12] Kibudde S. Anthracycline induced cardiotoxicity

in adult cancer patients: a prospective cohort study from

a specialized oncology treatment centre in Uganda[J].Afr

Health Sci,2019(19):1647–56.

[13] 李晨 , 孙立斌 , 邱文生 . 抗肿瘤治疗所致心脏

毒性的研究进展 [J]. 临床肿瘤学杂志 ,2016,21(12):1132-

1138.

[14] THEODOULOU M,EIDMAN A D.Cardiac

effects of adjuvant therapy for early breast cancer [J].Semin

Oncol,2003,30(6):730-739.

[15] 祁川川 , 陈建中 , 柴丽君 . 化疗期间心电图

异常对蒽环类药物引起乳腺浸润性导管癌患者慢性心

脏 毒性的预测价值 [J]. 中国全科医学 ,2017,20(9):1122-

1126.

[16] 张英 , 李青山 , 吕喜英 .Q-T 间期离散度在表

阿霉素心肌损伤中的早期预测价值 [J]. 河北医学 ,2014,20

(3):390-393.

[17] TASSAN -MANGINA S.Tissue Doppler

imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left

ventricular function during a prospective study[J].Eur J

Echocardiogr,2006,7(2):141-146.

[18] López-Sendón J, Álvarez-Ortega C, Zamora

Auñon P, Buño Soto A,Lyon AR, Farmakis D, et al.

Classification, prevalence, and outcomes of anticancer

therapy-induced cardiotoxicity: the CARDIOTOX

registry. Eur Heart J,2020(41):1720–9.

[19] KOH E,NAKAMURA T.Troponin-T and brain

natriuretic peptide as predictors for adria mycin-induced

cardiomyopathy in rats[J].Cric,2004,68(2):163-167.

[20] YEH ET,BICKFORD CL.Cardiovascular

complications of cancer ther-apy: incidence,

pathogenesis, diagnosis, and management[J].J Am Coll

Cardiol,2009,53(24):2231-2247.

[21] Liesse K, Harris J, Chan M, Schmidt ML, Chiu

B. Dexrazoxane Significantly Reduces Anthracyclineinduced Cardiotoxicity in Pediatric Solid Tumor Patients:

A Systematic Review.Journal of pediatric hematology/

oncology,2018(40):417-25.

[22] 王湘 , 白春梅 , 宁小红 . 抗肿瘤药物心脏毒性

的监测和治疗进展 [J]. 医学与哲学 ,2011,2(32):10-12.

[23] SACCO G.ACE inhibition and protection form

doxorubicin-induced cardiotoxicity inthe rat[J].Vascul

pharmacol,2009,50(5):166-170.

[24] 郝炜 , 刘胜 . 中医药防治蒽环类抗肿瘤药物所

致心脏毒性研究进展 [J]. 上海中医药杂志 ,2016,50(6):99-

102.

[25] Chen YL. Higenamine combined with[6]-

gingerol suppresses doxorubicin-triggered oxidative stress

and apoptosis in cardiomyocytes via upregulation of PI3K/

Akt pathway[J].Evid Based Complement Alternat Med,2013

(2013) : 97.

[26] Amgalan D. A small-molecule allosteric

inhibitor of BAX protects against doxorubicin-induced

cardiomyopathy[J]. Nat Cancer,2020,1 (3) : 315-328.

[27] Jing X,Yang J,Jiang L,et al. MicroRNA-29b

regulates the mitochondria-dependent apoptotic pathway by

targeting Bax in doxorubicin cardiotoxicity[J].Cell Physiol

Biochem, 2018, 48(2) : 692-704.


Refbacks

  • 当前没有refback。